CHASITY BLALOCK: Open Payments
NPI 1518398825 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 29 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $188 |
| ABBVIE INC. | 9 | $164 |
| Janssen Biotech, Inc. | 4 | $97 |
| Aimmune Therapeutics, Inc. | 4 | $82 |
| Ardelyx, Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Gilead Sciences, Inc. | 1 | $28 |
| QOL Medical, LLC | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: DUPIXENT, TREMFYA, MAVYRET, ZENPEP, IBSRELA, RINVOQ, ENTYVIO, SKYRIZI.
Industry payments across TN — which companies pay providers there.
